Trial Condition(s):

Contraception, Ovulation inhibition, Contraceptives, Oral

Study to compare cycle control and safety of the oral contraceptive SH T 00186 D (0.02 mg Ethinylestradiol and 3 mg Drospirenone) in a 21-day regimen vs. Mercilon®

Bayer Identifier:

90369

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

Study Completed

Trial Purpose

Please see attached Study Results Summary below.

Inclusion Criteria
No Inclusion Criteria Available
Exclusion Criteria
No Exclusion Criteria Available

Trial Summary

Enrollment Goal
441
Trial Dates
black-arrow
Phase
3
Could I receive a placebo?
No
Products
Yasminelle (EE20/DRSP, BAY86-5300)
Accepts Healthy Volunteers
N/A

Where to Participate

Locations
Status
LocationsStatus

Trial Design